NSW Branch | Toxicology: sodium channel blockers and lithium toxicity
This presentation will provide an overview of sodium channel blockers and lithium-induced toxicity. The focus is to understand treatment options in patients with sodium channel blocker poisoning and lithium toxicity and examine the evidence behind these.
- Identify presentations of sodium channel blocker poisoning and lithium toxicity
- Describe the mechanism and effect of these presentations
- Identify diagnostic methods for sodium channel blocker poisoning and lithium toxicity
- Outline treatment options and the evidence-base for these presentations
This webinar will commence at 7:00pm AEST
- Register in the purple box below, then click on 'cart' at the top of the page (or under your menu options) and continue through checkout.
- Still having trouble registering? Follow our handy ‘how to’ guide
- Click here to view our Terms and Conditions
* You will receive a confirmation email upon completion of your registration. If you do not receive this within 4 hours, you have not completed your registration and your space is not guaranteed. Please contact the secretariat by emailing email@example.com.
- A/Prof Betty Chan, Head of Clinical Toxicology Unit & Clinical Toxicologist, Prince of Wales Hospital; Emergency Physician, Prince of Wales Hospital; VMO Toxicologist, The Children’s Hospital at Westmead & NSW Poisons Information Centre; Conjoint Associate Professor, University of New South Wales
- Standard 3.1.2 Assess medication management practices and needs
- Standard 3.3.1 Undertake a clinical review
- Standard 3.5.2 Promote evidence-based medicine use
National Competency Standards Framework for Pharmacists in Australia, 2016
This activity has been accredited for 1 hour of Group-1 CPD (or 1 CPD credit), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2020/39.